Hi Guest
X
Real-Time Quote
Enter Company or MFGlaxoSmithKline Pharmaceuticals Ltd. - Research Center
Results | |
Statement | |
More |
Ratio |
Ratios
| Dec ' 08 | Dec ' 07 | Dec ' 06 | Dec ' 05 | Dec ' 04 | |
|---|---|---|---|---|---|
Per share ratios | |||||
| Adjusted EPS (Rs) | 54.89 | 48.46 | 43.05 | 36.04 | 31.57 |
| Adjusted cash EPS (Rs) | 56.82 | 50.37 | 44.93 | 37.89 | 33.57 |
| Reported EPS (Rs) | 68.07 | 63.48 | 64.40 | 59.28 | 38.15 |
| Reported cash EPS (Rs) | 70.00 | 65.38 | 66.27 | 61.13 | 40.15 |
| Dividend per share | 40.00 | 36.00 | 31.00 | 28.00 | 24.00 |
| Operating profit per share (Rs) | 71.83 | 66.58 | 58.59 | 51.92 | 46.36 |
| Book value (excl rev res) per share (Rs) | 181.94 | 160.67 | 141.05 | 111.99 | 105.84 |
| Book value (incl rev res) per share (Rs.) | 181.94 | 160.67 | 141.05 | 111.99 | 105.84 |
| Net operating income per share (Rs) | 197.91 | 186.37 | 182.04 | 174.03 | 156.63 |
| Free reserves per share (Rs) | 171.44 | 150.16 | 130.54 | 101.49 | 95.66 |
Profitability ratios | |||||
| Operating margin (%) | 36.29 | 35.72 | 32.18 | 29.83 | 29.59 |
| Gross profit margin (%) | 35.32 | 34.70 | 31.15 | 28.76 | 28.31 |
| Net profit margin (%) | 32.36 | 32.50 | 33.63 | 32.83 | 23.61 |
| Adjusted cash margin (%) | 27.01 | 25.79 | 23.46 | 20.98 | 20.77 |
| Adjusted return on net worth (%) | 30.16 | 30.16 | 30.52 | 32.17 | 29.82 |
| Reported return on net worth (%) | 37.41 | 39.50 | 45.66 | 52.92 | 36.03 |
| Return on long term funds (%) | 45.06 | 45.60 | 46.67 | 50.26 | 46.37 |
Leverage ratios | |||||
| Long term debt / Equity | - | - | - | 0.01 | - |
| Total debt/equity | - | - | - | 0.01 | - |
| Owners fund as % of total source | 99.63 | 99.57 | 99.53 | 99.49 | 99.58 |
| Fixed assets turnover ratio | 5.94 | 5.92 | 6.08 | 6.25 | 5.81 |
Liquidity ratios | |||||
| Current ratio | 1.94 | 0.90 | 0.94 | 0.89 | 1.12 |
| Current ratio (inc. st loans) | 1.94 | 0.90 | 0.94 | 0.89 | 1.12 |
| Quick ratio | 1.58 | 0.54 | 0.46 | 0.43 | 0.53 |
| Inventory turnover ratio | 7.85 | 8.51 | 7.09 | 7.32 | 6.62 |
Payout ratios | |||||
| Dividend payout ratio (net profit) | 68.75 | 66.35 | 54.88 | 53.86 | 71.13 |
| Dividend payout ratio (cash profit) | 66.85 | 64.41 | 53.33 | 52.22 | 67.59 |
| Earning retention ratio | 14.74 | 13.09 | 17.90 | 11.41 | 14.03 |
| Cash earnings retention ratio | 17.64 | 16.38 | 21.32 | 15.75 | 19.16 |
Coverage ratios | |||||
| Adjusted cash flow time total debt | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 |
| Financial charges coverage ratio | 1,357.13 | 472.16 | 426.97 | 209.86 | 175.86 |
| Fin. charges cov.ratio (post tax) | 1,129.05 | 409.93 | 417.04 | 220.55 | 138.66 |
Component ratios | |||||
| Material cost component (% earnings) | 38.96 | 39.04 | 42.23 | 43.23 | 43.64 |
| Selling cost Component | 5.64 | 6.24 | 6.70 | 6.93 | 7.09 |
| Exports as percent of total sales | 5.74 | 5.30 | 3.84 | 3.12 | 2.85 |
| Import comp. in raw mat. consumed | 29.86 | 27.41 | 27.94 | 26.17 | 34.04 |
| Long term assets / total Assets | 0.37 | 0.70 | 0.69 | 0.66 | 0.60 |
| Bonus component in equity capital (%) | 48.03 | 48.03 | 48.03 | 48.03 | 46.59 |